secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001437749-25-009483
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key narrows FY2024 net loss 49% to $4.3M on revenue of $6.9M (down 11%)
---------------------------------------------------------------------------

- Net loss improved to $4.3M ($2.10/sh) from $8.7M ($15.21/sh) in 2023, reflecting higher gross margin and lower costs.
- Revenue decreased 11% to $6.9M due to exit from low-margin Swivel Secure distribution; license fee revenue up 20% to $5.2M.
- Gross profit rose to $5.6M from $1.4M, benefiting from higher-margin license sales and a $3.6M hardware reserve in 2023.
- Operating expenses reduced 6% to $9.7M; cash used in operations down 23% to $2.91M.
- Recent partnerships include CA Ed Tech JPA (195 institutions), National Bank of Egypt, and a $910K biometric order from financial services firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925009483/0001437749-25-009483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925009483/bkyi20250327_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-009483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer